377 related articles for article (PubMed ID: 26362253)
21. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models.
Cooper AA; Gitler AD; Cashikar A; Haynes CM; Hill KJ; Bhullar B; Liu K; Xu K; Strathearn KE; Liu F; Cao S; Caldwell KA; Caldwell GA; Marsischky G; Kolodner RD; Labaer J; Rochet JC; Bonini NM; Lindquist S
Science; 2006 Jul; 313(5785):324-8. PubMed ID: 16794039
[TBL] [Abstract][Full Text] [Related]
22. Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration.
Soria FN; Engeln M; Martinez-Vicente M; Glangetas C; López-González MJ; Dovero S; Dehay B; Normand E; Vila M; Favereaux A; Georges F; Lo Bianco C; Bezard E; Fernagut PO
Hum Mol Genet; 2017 Jul; 26(14):2603-2615. PubMed ID: 28520872
[TBL] [Abstract][Full Text] [Related]
23. Phosphatidylinositol-3,4,5-trisphosphate interacts with alpha-synuclein and initiates its aggregation and formation of Parkinson's disease-related fibril polymorphism.
Choong CJ; Aguirre C; Kakuda K; Beck G; Nakanishi H; Kimura Y; Shimma S; Nabekura K; Hideshima M; Doi J; Yamaguchi K; Nakajima K; Wadayama T; Hayakawa H; Baba K; Ogawa K; Takeuchi T; Badawy SMM; Murayama S; Nagano S; Goto Y; Miyanoiri Y; Nagai Y; Mochizuki H; Ikenaka K
Acta Neuropathol; 2023 May; 145(5):573-595. PubMed ID: 36939875
[TBL] [Abstract][Full Text] [Related]
24. Glucocerebrosidase, a new player changing the old rules in Lewy body diseases.
Yang NY; Lee YN; Lee HJ; Kim YS; Lee SJ
Biol Chem; 2013 Jul; 394(7):807-18. PubMed ID: 23435096
[TBL] [Abstract][Full Text] [Related]
25. A double-hit in vivo model of GBA viral microRNA-mediated downregulation and human alpha-synuclein overexpression demonstrates nigrostriatal degeneration.
Polissidis A; Koronaiou E; Nikolopoulou G; Viel C; Nikatou M; Bogiongko M; Sardi SP; Xilouri M; Vekrellis K; Stefanis L
Neurobiol Dis; 2022 Feb; 163():105612. PubMed ID: 34995756
[TBL] [Abstract][Full Text] [Related]
26. Gaucher-related synucleinopathies: the examination of sporadic neurodegeneration from a rare (disease) angle.
Sardi SP; Cheng SH; Shihabuddin LS
Prog Neurobiol; 2015 Feb; 125():47-62. PubMed ID: 25573151
[TBL] [Abstract][Full Text] [Related]
27. Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies.
Mazzulli JR; Xu YH; Sun Y; Knight AL; McLean PJ; Caldwell GA; Sidransky E; Grabowski GA; Krainc D
Cell; 2011 Jul; 146(1):37-52. PubMed ID: 21700325
[TBL] [Abstract][Full Text] [Related]
28. Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse model.
Polinski NK; Martinez TN; Gorodinsky A; Gareus R; Sasner M; Herberth M; Switzer R; Ahmad SO; Cosden M; Kandebo M; Drolet RE; Buckett PD; Shan W; Chen Y; Pellegrino LJ; Ellsworth GD; Dungan LB; Hirst WD; Clark SW; Dave KD
PLoS One; 2021; 16(6):e0252325. PubMed ID: 34106956
[TBL] [Abstract][Full Text] [Related]
29. E46K mutant α-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type α-synuclein in Drosophila models of Parkinson's disease.
Sakai R; Suzuki M; Ueyama M; Takeuchi T; Minakawa EN; Hayakawa H; Baba K; Mochizuki H; Nagai Y
PLoS One; 2019; 14(6):e0218261. PubMed ID: 31242217
[TBL] [Abstract][Full Text] [Related]
30.
Granek Z; Barczuk J; Siwecka N; Rozpędek-Kamińska W; Kucharska E; Majsterek I
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768367
[TBL] [Abstract][Full Text] [Related]
31. D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model.
Kim D; Hwang H; Choi S; Kwon SH; Lee S; Park JH; Kim S; Ko HS
Acta Neuropathol Commun; 2018 Apr; 6(1):32. PubMed ID: 29703245
[TBL] [Abstract][Full Text] [Related]
32. A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy.
Cosden M; Jinn S; Yao L; Gretzula CA; Kandebo M; Toolan D; Hatcher NG; Ma L; Lemaire W; Adam GC; Burlein C; Minnick C; Flick R; Watt ML; Mulhearn J; Fraley M; Drolet RE; Marcus JN; Smith SM
Neurobiol Dis; 2021 Nov; 159():105507. PubMed ID: 34509608
[TBL] [Abstract][Full Text] [Related]
33. Glucocerebrosidase dysfunction in neurodegenerative disease.
Brooker SM; Krainc D
Essays Biochem; 2021 Dec; 65(7):873-883. PubMed ID: 34528667
[TBL] [Abstract][Full Text] [Related]
34. Glucosylceramide Associated with Gaucher Disease Forms Amyloid-like Twisted Ribbon Fibrils That Induce α-Synuclein Aggregation.
Paul A; Jacoby G; Laor Bar-Yosef D; Beck R; Gazit E; Segal D
ACS Nano; 2021 Jul; 15(7):11854-11868. PubMed ID: 34213307
[TBL] [Abstract][Full Text] [Related]
35. Glucocerebrosidase and parkinsonism: lessons to learn.
Marković I; Kresojević N; Kostić VS
J Neurol; 2016 May; 263(5):1033-1044. PubMed ID: 26995357
[TBL] [Abstract][Full Text] [Related]
36. Functional screening of lysosomal storage disorder genes identifies modifiers of alpha-synuclein neurotoxicity.
Yu M; Ye H; De-Paula RB; Mangleburg CG; Wu T; Lee TV; Li Y; Duong D; Phillips B; Cruchaga C; Allen GI; Seyfried NT; Al-Ramahi I; Botas J; Shulman JM
PLoS Genet; 2023 May; 19(5):e1010760. PubMed ID: 37200393
[TBL] [Abstract][Full Text] [Related]
37. Mutant GBA1 expression and synucleinopathy risk: first insights from cellular and mouse models.
Sardi SP; Singh P; Cheng SH; Shihabuddin LS; Schlossmacher MG
Neurodegener Dis; 2012; 10(1-4):195-202. PubMed ID: 22327140
[TBL] [Abstract][Full Text] [Related]
38. Gangliosides, α-Synuclein, and Parkinson's Disease.
Ledeen RW; Wu G
Prog Mol Biol Transl Sci; 2018; 156():435-454. PubMed ID: 29747823
[TBL] [Abstract][Full Text] [Related]
39. Abnormal accumulation of lipid droplets in neurons induces the conversion of alpha-Synuclein to proteolytic resistant forms in a Drosophila model of Parkinson's disease.
Girard V; Jollivet F; Knittelfelder O; Celle M; Arsac JN; Chatelain G; Van den Brink DM; Baron T; Shevchenko A; Kühnlein RP; Davoust N; Mollereau B
PLoS Genet; 2021 Nov; 17(11):e1009921. PubMed ID: 34788284
[TBL] [Abstract][Full Text] [Related]
40. Glucocerebrosidase activity, cathepsin D and monomeric α-synuclein interactions in a stem cell derived neuronal model of a PD associated GBA1 mutation.
Yang SY; Gegg M; Chau D; Schapira A
Neurobiol Dis; 2020 Feb; 134():104620. PubMed ID: 31634558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]